Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
To evaluate and compare the efficacy of two dosing regimens of oral edaravone in subjects with amyotrophic lateral sclerosis (ALS) based on the change in ALS Functional Rating Scale- Revised (ALSFRS-R) score from baseline up to Week 48:
Epistemonikos ID: ef9130ebcbfaad4990f679546e8b9f3716c80429
First added on: May 07, 2024